ACI Formulations Statistics

Total Valuation

ACI Formulations has a market cap or net worth of BDT 5.68 billion. The enterprise value is 8.72 billion.

Market Cap	5.68B
Enterprise Value	8.72B

Important Dates

The last earnings date was Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	Nov 18, 2024

Share Statistics

ACI Formulations has 47.25 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	47.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	12.54%
Owned by Institutions (%)	n/a
Float	16.06M

Valuation Ratios

The trailing PE ratio is 20.06.

PE Ratio	20.06
Forward PE	n/a
PS Ratio	1.14
PB Ratio	1.76
P/TBV Ratio	n/a
P/FCF Ratio	7.04
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.05, with an EV/FCF ratio of 10.81.

EV / Earnings	30.81
EV / Sales	1.75
EV / EBITDA	15.05
EV / EBIT	16.34
EV / FCF	10.81

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.97.

Current Ratio	1.24
Quick Ratio	0.89
Debt / Equity	0.97
Debt / EBITDA	5.43
Debt / FCF	3.90
Interest Coverage	2.03

Financial Efficiency

Return on equity (ROE) is 8.73% and return on invested capital (ROIC) is 5.19%.

Return on Equity (ROE)	8.73%
Return on Assets (ROA)	4.58%
Return on Capital (ROIC)	5.19%
Revenue Per Employee	5.05M
Profits Per Employee	287,412
Employee Count	985
Asset Turnover	0.68
Inventory Turnover	2.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.45%
50-Day Moving Average	126.95
200-Day Moving Average	131.13
Relative Strength Index (RSI)	48.27
Average Volume (20 Days)	20,358

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ACI Formulations had revenue of BDT 4.97 billion and earned 283.10 million in profits. Earnings per share was 5.99.

Revenue	4.97B
Gross Profit	1.38B
Operating Income	533.85M
Pretax Income	372.03M
Net Income	283.10M
EBITDA	579.30M
EBIT	533.85M
Earnings Per Share (EPS)	5.99

Full Income Statement

Balance Sheet

The company has 104.55 million in cash and 3.14 billion in debt, giving a net cash position of -3.04 billion or -64.33 per share.

Cash & Cash Equivalents	104.55M
Total Debt	3.14B
Net Cash	-3.04B
Net Cash Per Share	-64.33
Equity (Book Value)	3.24B
Book Value Per Share	68.45
Working Capital	920.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 953.44 million and capital expenditures -146.54 million, giving a free cash flow of 806.90 million.

Operating Cash Flow	953.44M
Capital Expenditures	-146.54M
Free Cash Flow	806.90M
FCF Per Share	17.08

Full Cash Flow Statement

Margins

Gross margin is 27.72%, with operating and profit margins of 10.73% and 5.69%.

Gross Margin	27.72%
Operating Margin	10.73%
Pretax Margin	7.48%
Profit Margin	5.69%
EBITDA Margin	11.64%
EBIT Margin	10.73%
FCF Margin	16.22%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 1.66%.

Dividend Per Share	2.00
Dividend Yield	1.66%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	39.30%
Buyback Yield	n/a
Shareholder Yield	1.66%
Earnings Yield	4.98%
FCF Yield	14.21%

Dividend Details

Stock Splits

The last stock split was on November 21, 2021. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 21, 2021
Split Type	Forward
Split Ratio	1.05

Scores

ACI Formulations has an Altman Z-Score of 2.38. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.38
Piotroski F-Score	n/a